215 related articles for article (PubMed ID: 36765508)
1. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
[TBL] [Abstract][Full Text] [Related]
2. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract][Full Text] [Related]
5. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
Nong L; Wang W; Liang L; Li D; Li X; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
[TBL] [Abstract][Full Text] [Related]
8. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A; Sweet K
J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
[TBL] [Abstract][Full Text] [Related]
9. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract][Full Text] [Related]
11. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm].
Han X; Ouyang MQ; Pei Q; Duan MH; Jiang XY; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):700-705. PubMed ID: 28954350
[No Abstract] [Full Text] [Related]
13. [Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang LL; Wang QX; Guan J; Zhou Y; Hu B; Feng Y; Zou L; Cheng H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1531-1536. PubMed ID: 37846712
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and Pathological Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Dong F; Zhang ZH; Gao F; Zhen JF; Zheng D; Zhao W; Li M; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):518-523. PubMed ID: 32319389
[TBL] [Abstract][Full Text] [Related]
15. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
16. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.
Deconinck E; Petrella T; Garnache Ottou F
Hematol Oncol Clin North Am; 2020 Jun; 34(3):491-500. PubMed ID: 32336414
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.
Zanotta S; Galati D; De Filippi R; Pinto A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338733
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
19. [Blastic plasmacytoid dendritic cell neoplasm with complete clinical remission with chemotherapy and central nervous system relapse: Report of one case].
Contreras L; Mercado L; Delgado C; Cabezas C; Starke L; Romero M; Ibieta F; Henríquez M; Chandia M
Rev Med Chil; 2017 Jan; 145(1):115-120. PubMed ID: 28393977
[TBL] [Abstract][Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]